HIAL
ABBV icon

Highland Investment Advisors LLC’s AbbVie ABBV Stock Holding History

Highland Investment Advisors LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$483K Buy
+1,921
New +$413K 0.21% 43

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Highland Investment Advisors LLC's ABBV Position: Q2 2026 in Review

Highland Investment Advisors LLC opened a new position in AbbVie (ABBV) in Q2 2026: 1,921 shares worth $483K. The stake represents 0.21% of the portfolio and ranks #43 among its holdings.

3,652 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Highland Investment Advisors LLC held 1,921 shares of AbbVie worth $483K as of Q2 2026.
  • AbbVie was a new Highland Investment Advisors LLC position in Q2 2026.
  • AbbVie made up 0.21% of Highland Investment Advisors LLC's portfolio in Q2 2026, its #43 holding.
  • 3,652 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Highland Investment Advisors LLC's 13F filing for Q2 2026, filed 13 Aug 2026.